Laurent M. Humeau

2021

In 2021, Laurent M. Humeau earned a total compensation of $2.3M as Chief Scientific Officer at Inovio Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$174,754
Option Awards$860,581
Salary$484,508
Stock Awards$750,726
Other$13,000
Total$2,283,569

Humeau received $860.6K in option awards, accounting for 38% of the total pay in 2021.

Humeau also received $174.8K in non-equity incentive plan, $484.5K in salary, $750.7K in stock awards and $13K in other compensation.

Rankings

In 2021, Laurent M. Humeau's compensation ranked 5,515th out of 12,406 executives tracked by ExecPay. In other words, Humeau earned more than 55.5% of executives.

ClassificationRankingPercentile
All
5,515
out of 12,406
56th
Division
Manufacturing
2,330
out of 5,492
58th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
284
out of 798
64th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
171
out of 519
67th
Industry
Surgical and Medical Instruments and Apparatus
111
out of 324
66th

Pay ratio

Laurent M. Humeau's Pay$2,283,569
Median Employee's Pay$180,313
Pay Ratio

13

to 1

In 2021, the annual total compensation of Laurent M. Humeau was $2,283,569.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $180,313.

The ratio of Laurent M. Humeau's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on March 25, 2022.

Humeau's colleagues

We found three more compensation records of executives who worked with Laurent M. Humeau at Inovio Pharmaceuticals in 2021.

2021

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2021

Jacqueline Shea

Inovio Pharmaceuticals

Chief Operating Officer

2021

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

News

You may also like